Pyridine, 2,4,6-trichloro-

2,4,6-trichloro-pyridin · 2,4,6-Trichloropyridine · Pyridine,2,4,6-trichloro- · 2 4 6-TRICHLOROPYRIDINE 97 · 2,4,6-Trichloropyridine,98% · 2,4,6-Trichloropyridine ISO 9001：2015 REACH

https://huagongshe.com/de/chemical/27665

Molekülstruktur von Pyridine, 2,4,6-trichloro-

Identifikatoren & physikalische Daten

CAS No.	16063-69-7
Summenformel	C5H2Cl3N
Durchschnittliche Molmasse	182,43 g/mol
Monoisotopische Masse	180,9252821 g/mol
SMILES	Clc1cc(Cl)nc(Cl)c1
InChIKey	FJNNGKMAGDPVIU-UHFFFAOYSA-N
PubChem CID	27665
EC No.	628-736-3
DTXSID	DTXSID80166951

Chemische & physikalische Eigenschaften

XLogP	2,7
Polarare Oberfläche (TPSA)	12,9
H-Brücken-Donoren	0
H-Brücken-Akzeptoren	1
Frei drehbare Bindungen	0
Schwere Atome	9
Formalladung	0
Komplexität	88,2
LogP (Verteilungskoeffizient)	2.68
Schmelzpunkt	33-37 °C (lit.)
Siedepunkt	217.5-218.5 °C
Dichte	1.539±0.06 g/cm3(Predicted)
Flammpunkt	>230 °F
Lagerbedingungen	2-8°C
pKa (Säurekonstante)	-2.93±0.10(Predicted)
Aggregatzustand	Crystalline Powder
Farbe	Yellow to yellow-brown
Löslichkeit	Sparingly soluble in water. (0.113 mm Hg at 25°C)
InChI	InChI=1S/C5H2Cl3N/c6-3-1-4(7)9-5(8)2-3/h1-2H
InChIKey	FJNNGKMAGDPVIU-UHFFFAOYSA-N
SMILES	C1(Cl)=NC(Cl)=CC(Cl)=C1

Sicherheit & Vorschriften

GHS-Einstufung	DangerH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]P261, P264, P264+P265, P270, P272, P280, P301+P317, P302+P352, P305+P354+P338, P317, P321, P330, P333+P317, P362+P364, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 43 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard Classes and Categories	Acute Tox. 4 (100%)
Wassergefährdungsklasse (WGK)	3
Zollcode	29333990
RTECS-Nr.	UU0875000
R-Sätze (R)	22-41-43
Gefahrensymbole	Xn,Xi
Sicherheitshinweise (S)	26-36/37/39
Lagerklasse	11 - Combustible Solids
Gefahrenklasse	Acute Tox. 4 OralEye Dam. 1Skin Sens. 1

Anwendungen & Verwendung

Verwenden

2,4,6-Trichloropyridine is used as pharmaceutical intermediates.